Replies to post #21207 on Charlotte's Web Holdings Inc (CWBHF)

[Wolf-man jack]

WISE WQLF SAYS;
The stock went to $10.38 soon as the deal was consummated in late May. Then it fell to $.90 cents per share in late December as those that got sucked in took end of year tax breaks on their losses. Tilray, MLB Cartel, Stanley Fools Company, and Bloody British Cancer (BBC) companies combined are not helping the itsy itsy bitsy spider web company at ALL YQU Understand. Have Mercy WISE WQLF Ahooooooo

Cardvic Said;

Tilray has a history of trying to rescue lost causes. Look at the HEXO deal last year as an example.

Dr. Joong J Fang Said;

The Good

Doing Nothing At All

The Bad

Tilray and HEXO BSA

https://finance.yahoo.com/news/hexo-enters-definitive-agreement-tilray-122100120.html

And The Ugly

Tilray and Charlotte’s Web BSA

https://finance.yahoo.com/news/charlottes-enters-strategic-alliance-tilray-110000819.html

Effective as of November 1, 2022, Charlotte’s Web Holdings, Inc. (the “Company”) entered into a Manufacturing and Sales License Agreement (the “Agreement”) with Aphria, Inc., an Ontario corporation, an affiliate of Tilray Brands, Inc. (“Tilray”), pursuant to which the parties entered into a strategic alliance by which Tilray will have the rights to licensing, manufacturing, quality, marketing and distribution of Charlotte’s WebTM CBD hemp extract products in Canada. Pursuant to the Agreement, Tilray has the exclusive rights to the sale and distribution of Charlotte’s WebTM CBD hemp extract products in all channels, including medical, adult-use, and pharmacy (when permissible) where such products may be legally sold and distributed in Canada. Additionally, Tilray will have the first right exclusively to bring the Company’s new products into Canada. If Tilray fails to exercise such right within 30 days of being given notice by the Company of the proposed product introduction, the Company will have the right to seek an alternative distributor for such product introduction in Canada. Under the Agreement, Tilray’s responsibilities include sourcing raw materials, manufacturing the Company’s products, and packaging and labeling the Company’s products, all in accordance with applicable laws, the Company’s quality standards and specifications.

In consideration for the Agreement, Tilray has agreed to spend in each calendar year during the term of the Agreement (other than 2022) a minimum of five percent (5%) of net sales per year on advertising, retail marketing, direct to consumer advertising, and similar third-party marketing expenditures for the Company’s products. In addition, Tilray will spend an additional $250,000 (Canadian dollars) on marketing in the first contract year following 2022 to launch the Company’s brand into the Canadian market. Tilray will also pay the Company a monthly royalty of 10% of all net sales revenue received by Tilray from sales to third-party entities during the prior month.

The Agreement expires on October 31, 2026, unless earlier terminated by either party in accordance with the terms of the Agreement. The Agreement is also subject to termination for convenience by either party upon 6 months’ notice given on or after October 31, 2024.

Other than the Agreement, there are no other agreements or relationship between the Company and Tilray.

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which is included as Exhibit 10.1 to this Current Report on Form 8-K.


https://www.sec.gov/ix?doc=/Archives/edgar/data/0001750155/000127956922001819/charlotteform8k.htm